[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fxLN3MUwXCdr5RPjwZYIDpOj8CHyjOmngWTgoKXPtZbg":3,"$fCHXropzzafDGzahA7wKR1paAzS_rBDvxoXn1IFiAIxM":32,"$f3Ft0rKFJHppdzE-vuveecxx1BUcg9iOlMLtyzf_MJDg":75},[4,8,12,16,20,24,28],{"title":5,"slug":6,"path":7},"About Microbeonline.com","about-microbeonline-com","\u002Fabout-microbeonline-com\u002F",{"title":9,"slug":10,"path":11},"About Me","about-me","\u002Fabout-microbeonline-com\u002Fabout-me\u002F",{"title":13,"slug":14,"path":15},"Advertise with Us","advertise-us","\u002Fadvertise-us\u002F",{"title":17,"slug":18,"path":19},"Privacy Policy","privacy-policy","\u002Fprivacy-policy\u002F",{"title":21,"slug":22,"path":23},"Abbreviations","abbreviations","\u002Fabbreviations\u002F",{"title":25,"slug":26,"path":27},"Microbes","microbes","\u002Fmicrobes\u002F",{"title":29,"slug":30,"path":31},"Books","recommended-books","\u002Frecommended-books\u002F",{"type":33,"data":34},"blog",{"slug":35,"title":36,"description":37,"seoTitle":38,"seoDescription":38,"author":39,"createdDate":40,"lastUpdatedDate":41,"draft":42,"category":43,"image":38,"body":44,"faq":45,"tags":73,"related":74},"anti-streptolysin-o-aso-test-principle-procedure-and-interpretation","ASO Titer Test: How to Interpret Results (Single vs Paired) and Cutoffs","What an ASO titer actually means: adult vs child cutoffs, when a single titer is diagnostic vs when you need paired sera, and why a raised ASO alone never confirms rheumatic fever. Bench procedure included.",null,"Acharya Tankeshwar","2013-08-08","2026-07-19",false,"immunology","A 9-year-old is brought to a clinic in Kathmandu three weeks after a sore throat that was never cultured. Now she has migrating joint pain and a new heart murmur. The throat swab is negative, because the streptococci are long gone. But her blood still carries the immune system's paper trail: antibodies raised against streptolysin O, the toxin group A *Streptococcus* used weeks ago. The ASO titer does not tell you she has a strep infection today. It tells you she had one recently enough for rheumatic fever to be the explanation in front of you. That single distinction, between a current infection and an antecedent one, is the entire clinical reason this test exists, and it is where most interpretation goes wrong.\n\n### Why the ASO test matters clinically\n\nThe throat swab and rapid strep test answer one question: is there strep in the throat right now? By the time post-streptococcal complications appear, that window has closed. Rheumatic fever and post-streptococcal glomerulonephritis surface 2 to 3 weeks after the original infection, when cultures are already negative. The ASO titer fills that gap. It is retrospective evidence, confirming that a group A streptococcal infection occurred recently enough to plausibly explain immune-mediated sequelae. This is why ASO is one of the antibody criteria used to satisfy the \"evidence of preceding streptococcal infection\" requirement in the modified Jones criteria for acute rheumatic fever. It supports the diagnosis; it does not make it.\n\nMost people infected with group A streptococci produce anti-streptolysin O (ASO) antibodies. In infections caused by β-hemolytic streptococci, streptolysin O is one of two hemolysins the bacteria release. Streptolysin S is oxygen-stable but poorly immunogenic, so it provokes little antibody response. Streptolysin O is oxygen-labile and strongly immunogenic, which is why it, and not streptolysin S, is the target of a serologic test. It stimulates the production of ASO antibodies in serum.  The presence and the level of these [antibodies](\u002Fimmunoglobulin-structure\u002F) in the serum may reflect the nature and severity of the infection. Rheumatic fever and poststreptococcal glomerulonephritis tend to occur 2 to 3 weeks after the initial streptococcal infection.\n\nStreptolysin O is an enzyme that lyses RBC membranes and is responsible for the zone of [beta-hemolysis](\u002Fblood-agar-composition-preparation-uses-and-types-of-hemolysis\u002F) around colonies of group A streptococci seen on agar plates. Classically, ASO antibodies were detected by demonstrating serum’s capacity to inhibit or neutralize the lysis of RBC membranes by streptolysin O. The test principle, procedure, and interpretation presented here is based on the latex anti-streptolysin O (ASO) test.\n\n> Assays for anti-DNase B (ADB) antibodies are also available to diagnose group A streptococcal infection. ADB test detects antibodies against the B isoenzyme of streptococcal DNases (also called streptodornase), a group of bacterial enzymes that depolymerize DNA.\n\n### Principle\n\nThe ASO titer (ASOT) tends to rise a week following infection, peaks at 3 to 5 weeks, begins to fall at 8 weeks, and returns to pre-infection levels at around 8 months. Stronger ASO responses follow throat infections than skin infections. Skin lipids, in particular free cholesterol, bind and neutralize streptolysin O at the site, blunting its immunogenicity. This has a practical consequence: in suspected post-streptococcal glomerulonephritis following skin infection (pyoderma), ASO is often unhelpful, and anti-DNase B is the more reliable marker. Qualitative and semi-quantitative determination of anti-streptolysin O antibodies (ASO) in serum can be performed using a rapid latex agglutination test.\n\nASO latex reagent is a stabilized buffered suspension of **polystyrene latex particles coated with Streptolysin O**. When the latex reagent is mixed with a serum containing ASO, **agglutination** occurs.\n\n![ASO Latex test - ASO Latex test](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002FASO-Latex-test-300x225.jpg)Figure: ASO Latex test\n\nIdeally, titers should be measured in both the acute and convalescent phases (2 to 4 weeks apart) to observe a rise in titer. However, single titers are frequently used in low-resource settings.\n\nThe sensitivity of the latex reagent has been adjusted to yield [agglutination](\u002Fagglutination-types\u002F) when the level of **ASO is greater than 200 IU\u002FmL**, a level determined to be indicative of disease by epidemiological and clinical studies. With this reagent, sera containing between 200 IU\u002FmL and 3500 IU\u002FmL of ASO give a reactive (agglutination) result; this is the working range of the latex kit, not a clinical severity scale.\n\n### Sample Collection and Handling\n\nOnly fresh serum specimens should be used. Plasma must not be used since fibrinogen may cause non-specific agglutination of the latex. It is preferable to test samples on the same day as collected. Serum samples may be stored at 2-8°C for up to 48 hours prior to testing. If longer storage is necessary, sera should be stored frozen at -20°C.\n\n### Materials used in the ASO Test\n\n1. **ASO antigen:** A stabilized buffered suspension of polystyrene latex particles coated with Streptolysin O and 0.1% sodium azide as a preservative. Shake well prior to use.\n2. **ASO positive control**: Human serum-containing more than 200 IU\u002FmL ASO and 0.1% sodium azide as a preservative.\n3. **ASO negative control**: Human serum containing 0.1% sodium azide as a preservative.\n4. Sufficient disposable pipettes.\n5. Glass test slide.\n\n### Procedure for Anti-streptolysin O Test\n\n1. Bring all test reagents and samples to room temperature.\n2. Use a disposable pipette to draw up and place one free-falling drop of each undiluted sample into its identified circle of the slide. Retain each pipette for mixing in step 5.\n3. Deliver one free-falling drop of positive and negative control into its identified circle.\n4. Mix the ASO latex reagent by gently shaking. Add one free-falling drop of a reagent to each control and sample.\n5. Using the flattened end of the appropriate plastic pipette as a stirrer (step 2), thoroughly mix each sample with reagent within the full area of the circle.\n6. Discard the disposable pipette.\n7. Slowly rock the slide for exactly two (2) minutes and observe for agglutination under a high-intensity light.\n8. Record results.\n9. Clean and disinfect the glass slide after use per [your laboratory's biosafety protocol.](https:\u002F\u002Fmicrobeonline.com\u002Fprimary-bio-safety-levels-and-agents-of-disease\u002F)\n\n### Test Result\n\nA test sample is considered to contain ASO antibodies in excess of 200 IU\u002FmL when agglutination (clumping) is observed when compared to the result of the negative control.\n\n![ - ASO titer results](https:\u002F\u002Fassets.microbeonline.com\u002Fblogs\u002FASO-Titre-test.png)Figure: ASO titer results\n\n## Interpretation\n\n### **Single titer vs paired sera**\n\nThere are two ways to read an ASO result, and choosing the right one is the crux of the test.\n\n**A rise in titer of twofold or greater between an acute-phase and a convalescent-phase sample** (drawn 2 to 4 weeks apart) is the strongest evidence of a recent group A streptococcal infection. A rising titer is unambiguous; a single high value is not, because it cannot tell you whether the antibody is climbing, plateaued, or already falling from an old infection.\n\n**Paired sera are the ideal.** In practice, in low-resource and endemic settings, patients are frequently lost to follow-up and a single sample is all that is available. Here a single titer above the age-appropriate upper limit of normal is accepted as sufficient evidence of antecedent infection, and this single-titer-versus-ULN approach is explicitly permitted under the 2015 Jones criteria.\n\n### Age-stratified cutoffs\n\n\"Elevated\" is not one number. Because group A streptococcal infection is far more common in children, healthy children carry higher baseline titers than adults, and an age-stratified upper limit of normal must be used.\n\nAs a working guide, titers above roughly 200 IU\u002FmL in adults and above roughly 300 IU\u002FmL in school-aged children are considered elevated. These are conventional reference figures; the true upper limit of normal is the 80th percentile of the local healthy population and varies geographically. In high-incidence settings, applying a Western cutoff of 200 IU\u002FmL to children causes systematic over-diagnosis of rheumatic fever, which is why locally derived, age-stratified values are preferred wherever they exist.\n\n### The interpretation must stay tied to the clinic\n\nASO titer should be interpreted with considerable caution in the absence of a convincing clinical history of rheumatic fever or glomerulonephritis. A raised titer confirms recent exposure, nothing more. Many healthy people in endemic areas carry elevated titers with no disease. An elevated ASO on its own never confirms rheumatic fever; it contributes one piece to the Jones criteria alongside the clinical findings.\n\nASO titer may be interpreted either by **comparison of acute and convalescent-phase titers** or **against reference upper limit of normal values**. **Rise in titer (≥ twofold)** from the acute phase to the convalescent phase is the best evidence of antecedent infection with group A streptococci. In the area, where rheumatic fever or poststreptococcal glomerulonephritis is endemic, a single initial titer more than (>) upper limit of normal value is diagnostic.\n\nAs group A streptococcal infection is more common in children than adults, age-stratified upper limit of normal reference values should be used while interpreting the serological results. ASO titer should be interpreted with considerable caution, especially in the absence of a convincing history of rheumatic fever or glomerulonephritis.\n\n### Limitations\n\n- False-negative ASO results can occur for patients with hyperlipidemia.\n- False-positive ASO results may occur due to cross-reactivity in patients with myeloma, hypergammaglobulinemia, liver disease, and autoimmune disease with elevated rheumatoid factor.\n\n## How to Remember\n\n**Skin soaks up the signal.** Skin infections give weak ASO responses because skin cholesterol mops up streptolysin O before the immune system sees much of it. So after impetigo\u002Fpyoderma, don't trust ASO, reach for anti-DNase B. Picture the streptolysin O being \"absorbed\" into oily skin and never reaching the bloodstream.\n\n**Rising beats high.** A titer that is *rising* across two samples beats a single *high* number every time, because \"high\" could be an old scar rather than a fresh wound. When you can only get one sample, you're no longer measuring change, so you have to compare against the age-matched normal ceiling instead.\n\n## Key exam facts in one table\n\n| Point | What to remember |\n| --- | --- |\n| Target antigen | Streptolysin O, an oxygen-labile, immunogenic hemolysin of group A *Streptococcus* |\n| Why not streptolysin S | Streptolysin S is oxygen-stable and poorly immunogenic, so it raises little antibody |\n| What a positive means | Recent (antecedent) GAS infection, not a current one |\n| Titer kinetics | Rises \\~1 week post-infection, peaks at 3 to 5 weeks, falls by \\~8 weeks, back to baseline by \\~8 months |\n| Best evidence of infection | Twofold or greater rise between paired acute and convalescent sera (2 to 4 weeks apart) |\n| Single-titer rule | A single titer above the age-specific ULN is acceptable in endemic\u002Flow-resource settings (allowed by 2015 Jones criteria) |\n| Adult cutoff | Elevated above \\~200 IU\u002FmL (locally validated 80th-percentile ULN preferred) |\n| Child cutoff | Higher, \\~300 IU\u002FmL in school-aged children; children have higher baselines |\n| Throat vs skin | Strong response after pharyngitis; weak after skin infection (cholesterol neutralizes SLO). Use anti-DNase B after skin infection |\n| Detection threshold (latex) | Latex reagent agglutinates when ASO exceeds 200 IU\u002FmL |\n| Sample | Fresh serum only; never plasma (fibrinogen causes non-specific agglutination) |\n| False negative | Hyperlipidemia |\n| False positive | Myeloma, hypergammaglobulinemia, liver disease, elevated rheumatoid factor |\n| Clinical rule | Elevated ASO alone never confirms rheumatic fever; it satisfies one Jones-criteria element |\n\n### Where students get confused\n\n**\"A high ASO means the patient has a strep infection now.\"** No. It means they *had* one, recently. By design, ASO is used precisely when the organism is already gone and cultures are negative. Confusing \"recent\" with \"current\" is the single most common error.\n\n**\"Elevated ASO confirms rheumatic fever.\"** It does not. It confirms antecedent infection, one required piece of the Jones criteria. Plenty of healthy people in endemic areas have elevated titers and no disease.\n\n**\"200 IU\u002FmL is the cutoff, full stop.\"** The cutoff is age-dependent and population-dependent. Children run higher baselines, and the real upper limit of normal is the 80th percentile of the local healthy population. Applying an adult or Western number to a child in an endemic area over-diagnoses disease.\n\n**\"A single normal ASO rules out rheumatic fever.\"** No. Some patients are non-responders, and the titer may already be falling when symptoms appear. This is exactly why anti-DNase B exists as a second, complementary marker, and why one negative antibody test does not close the question.\n\n**\"Why bother with anti-DNase B at all?\"** Because after skin infections ASO is unreliable (cholesterol blunts the response), and because pairing the two antibodies catches more true infections than either alone.\n\n**References**\n\n1. Gray, G. C., Struewing, J. P., Hyams, K. C., Escamilla, J., Tupponce, A. K., & Kaplan, E. L. (1993). Interpreting a single antistreptolysin O test: a comparison of the \"upper limit of normal\" and likelihood ratio methods. *Journal of Clinical Epidemiology, 46*(10), 1181–1185.\n2. Machado, C. S., Ortiz, K., Martins, A. de L., Martins, R. S., & Machado, N. C. (2001). Antistreptolysin O titer profile in acute rheumatic fever diagnosis. *Jornal de Pediatria, 77*(2), 105–111.\n3. Tille, P. M. (2022). *Bailey & Scott's Diagnostic Microbiology* (15th ed.). Elsevier.\n4. Procop, G. W., et al. (2017). *Koneman's Color Atlas and Textbook of Diagnostic Microbiology* (7th ed.). Wolters Kluwer.\n5. Gewitz, M. H., et al. (2015). Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. *Circulation, 131*(20), 1806–1818.",[46,49,52,55,58,61,64,67,70],{"question":47,"answer":48},"Why is ASO titer elevated in rheumatic fever even after the streptococcal throat infection has resolved?","Anti-streptolysin O antibodies are produced by the immune system in response to streptolysin O toxin released during Group A Streptococcal pharyngitis. The kinetics of the ASO response mean that titers begin rising approximately 1 week after infection, peak at 3–5 weeks, and remain elevated for months to years. Rheumatic fever develops 2–4 weeks after the triggering streptococcal throat infection — precisely the period when ASO titers are at or near their peak. By the time the patient presents with symptoms of rheumatic fever (migratory polyarthritis, carditis, chorea), the original streptococcal infection has cleared, throat cultures are negative, and the organism can no longer be found. The elevated ASO titer is therefore the only readily available serological evidence that a streptococcal infection preceded the current illness. This is why ASO testing is included in the evidence of preceding streptococcal infection criterion of the Jones Criteria for rheumatic fever diagnosis — it provides retrospective confirmation of the aetiological trigger even when the causative organism is no longer detectable.",{"question":50,"answer":51},"Why is Anti-DNase B preferred over ASO for diagnosing post-streptococcal complications after skin infections?","Streptolysin O, the antigen detected by the ASO test, has reduced immunogenicity at skin sites compared to pharyngeal sites. Free cholesterol present in normal skin binds to streptolysin O and inactivates it before it can stimulate a significant antibody response. As a result, Group A Streptococcal skin infections (impetigo, cellulitis) produce weaker or absent ASO responses — ASO sensitivity for skin-related post-streptococcal complications is only approximately 30%, compared to 80% for throat infections. Anti-DNase B measures antibodies against streptococcal DNase B (streptodornase B), an enzyme produced by virtually all Group A Streptococcal strains regardless of infection site. DNase B maintains its immunogenicity at skin sites and produces robust antibody responses after both pharyngeal and cutaneous infections. Post-streptococcal glomerulonephritis (PSGN) commonly follows streptococcal impetigo in tropical settings — in children from endemic regions presenting with PSGN, Anti-DNase B will be elevated in approximately 80% of cases, while ASO may be normal in up to 70%. Testing both simultaneously maximises sensitivity to approximately 95%.",{"question":53,"answer":54},"What are the main causes of false positive ASO results, and how do they affect clinical interpretation?","False positive ASO results — elevated titers in the absence of recent Group A Streptococcal infection — occur in several clinical conditions. Hyperlipidaemia can produce a technical false positive by interfering with the latex agglutination reaction; the lipid particles in the serum may agglutinate the latex non-specifically, producing a reactive result. Elevated levels of immunoglobulins from any cause — including multiple myeloma, liver disease (cirrhosis and hepatitis), and systemic autoimmune diseases with polyclonal hypergammaglobulinaemia — can also produce non-specific agglutination. Rheumatoid factor (elevated in rheumatoid arthritis and other autoimmune conditions) can interfere with antibody-based agglutination tests and produce false positives. Geographic and age-related variation in background titers is also important: in regions with high streptococcal endemicity, healthy children may have titers of 300–400 IU\u002FmL without active disease, which would exceed the standard adult cut-off of 200 IU\u002FmL. This is why the ASO result must always be interpreted in clinical context — an elevated ASO without supporting clinical features of rheumatic fever or post-streptococcal glomerulonephritis should not be reported as diagnostic of those conditions.",{"question":56,"answer":57},"Does a high ASO titer mean I currently have a strep infection?","No. A high ASO titer means you had a group A streptococcal infection recently, usually within the past several weeks. The test is designed for situations where the infection has already cleared and throat cultures are negative, which is exactly when post-streptococcal complications appear.",{"question":59,"answer":60},"What is a normal ASO titer?","It depends on age and location. As a general guide, titers above about 200 IU\u002FmL in adults and about 300 IU\u002FmL in school-aged children are considered elevated. Children have higher normal baselines, and the true cutoff is the 80th percentile of the local healthy population.",{"question":62,"answer":63},"Why do I need two blood samples for an ASO test?","A rise of twofold or more between an acute sample and a convalescent sample taken 2 to 4 weeks later is the strongest evidence of recent infection. A single value cannot tell you whether the titer is rising, steady, or already falling. Where follow-up is difficult, a single titer above the age-specific normal limit is accepted instead.",{"question":65,"answer":66},"Can ASO confirm rheumatic fever?","No. An elevated ASO confirms only that a recent streptococcal infection occurred. It satisfies one element of the modified Jones criteria and must be combined with clinical findings to diagnose rheumatic fever.",{"question":68,"answer":69},"When should anti-DNase B be used instead of ASO?","After skin infections (pyoderma, impetigo), the ASO response is weak because skin cholesterol neutralizes streptolysin O. Anti-DNase B is the more reliable marker in that setting, and testing both antibodies detects more true infections than either alone.",{"question":71,"answer":72},"Why can't plasma be used for the ASO latex test?","Plasma contains fibrinogen, which can cause non-specific clumping of the latex particles and a false result. Only fresh serum should be used.",[],[],[76,82,89,94,98,102,107,112,116,120],{"slug":77,"name":39,"description":78,"image":79,"body":80,"postCount":81},"acharya-tankeshwar","Editor-in-chief","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Ftankeshwar-acharya-author-microbeonline.jpg","***Tankeshwar Acharya, MSc (Medical Microbiology)***\n\n*Tankeshwar Acharya is an Assistant Professor in the Department of Microbiology at Patan Academy of Health Sciences (PAHS), Nepal, where he has been teaching and practicing clinical microbiology for over 14 years. He is the founder of Microbe Online, one of the leading free microbiology education resources on the web, covering bacteriology, mycology, parasitology, immunology, and clinical laboratory diagnostics written from direct experience in both the classroom and the diagnostic laboratory.*",433,{"slug":83,"name":84,"description":85,"image":86,"body":87,"postCount":88},"ashma-shrestha","Ashma Shrestha","SEO Copywriter and Science Communicator\nKathmandu, Nepal","https:\u002F\u002Fassets.microbeonline.com\u002Fauthors\u002Fashma-shrestha.png","Ashma Shrestha holds a Master of Science in Medical Microbiology from the Institute of Science and Technology (IOST), Tribhuvan University, Nepal, where she developed a strong foundation in virology, molecular biology, and diagnostic microbiology.\n\nShe now works as an SEO Copywriter at Resolution Digital, where she combines her scientific training with research-driven content strategy. She is certified in Google Analytics and Google Business Profile (GBP), and brings a data-informed approach to science communication writing content that is not only accurate but structured to reach and serve the students who need it most.\n\nAt microbeonline, Ashma contributes articles primarily in virology and molecular biology, areas she finds most compelling for their mechanistic depth and their growing clinical relevance. Her writing reflects the same standard the site is built on: factual rigor, clear explanation of the *why* behind microbiology concepts, and content that helps students move from memorization to genuine understanding.\n\nShe is passionate about making complex microbiological concepts accessible without sacrificing accuracy; a skill that sits at the intersection of her scientific training and her professional work in content and SEO.",81,{"slug":90,"name":91,"description":92,"image":38,"body":38,"postCount":93},"sushmita-baniya","Sushmita Baniya","Author \u002F Contributor",32,{"slug":95,"name":96,"description":92,"image":38,"body":38,"postCount":97},"samikshya-acharya","Samikshya Acharya",20,{"slug":99,"name":100,"description":92,"image":38,"body":38,"postCount":101},"alisha-tripathi","Alisha Tripathi",6,{"slug":103,"name":104,"description":105,"image":38,"body":38,"postCount":106},"aastha-shrestha","Aastha Shrestha"," Author \u002F Contributor",10,{"slug":108,"name":109,"description":110,"image":38,"body":38,"postCount":111},"guest-author","Guest Author","Guest Author \u002F Contributor",2,{"slug":113,"name":114,"description":92,"image":38,"body":38,"postCount":115},"srijana-khanal","Srijana Khanal",18,{"slug":117,"name":118,"description":110,"image":38,"body":38,"postCount":119},"dr-poonam-acharya","Dr. Poonam Acharya",1,{"slug":121,"name":122,"description":92,"image":38,"body":123,"postCount":124},"nisha-rijal","Nisha Rijal","**Nisha Rijal** is a microbiologist and quality assurance specialist. She served for nearly 12 years as a microbiologist at the National Public Health Laboratory (NPHL), Nepal's national reference laboratory, and continues to work as a consultant microbiologist in international public health organization. ",51]